Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 74.7x - 82.6x | 78.7x |
| Selected Fwd P/E Multiple | 13.2x - 14.6x | 13.9x |
| Fair Value | €8.30 - €9.17 | €8.73 |
| Upside | -21.0% - -12.7% | -16.8% |
| Benchmarks | - | Full Ticker |
| MPH Health Care AG | - | XTRA:93M1 |
| Biofrontera AG | - | XTRA:B8FK |
| Cantourage Group SE | - | XTRA:HIGH |
| Labiana Health, S.A. | - | DB:8RK |
| Eevia Health Oyj | - | XSAT:EEVIA |
| Apontis Pharma AG | - | DB:APPH |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 93M1 | B8FK | HIGH | 8RK | EEVIA | APPH | |||
| XTRA:93M1 | XTRA:B8FK | XTRA:HIGH | DB:8RK | XSAT:EEVIA | DB:APPH | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 23.7% | NM- | NM- | -17.3% | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | 8.5% | -342.2% | 105.0% | 105.7% | -63.4% | 106.7% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -252.3% | -23.9% | 2.3% | -6.8% | -55.2% | -5.6% | ||
| Prior Fiscal Year | 85.8% | -1.1% | 2.3% | -7.4% | -19.2% | -30.6% | ||
| Latest Fiscal Year | 49.0% | -20.1% | 3.6% | 0.4% | -111.6% | 1.6% | ||
| Latest Twelve Months | 49.0% | -4.1% | 3.6% | 0.4% | -133.0% | 1.6% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 1.3x | -3.7x | NA | 7.4x | -3.4x | 21.6x | ||
| Price / LTM Sales | 1.1x | 0.7x | 23.4x | 0.4x | 0.4x | 1.9x | ||
| LTM P/E Ratio | 2.3x | -17.1x | 647.9x | 108.3x | -0.3x | 119.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -17.1x | 2.3x | 647.9x | |||||
| Historical LTM P/E Ratio | -156.6x | 8.0x | 119.9x | |||||
| Selected P/E Multiple | 74.7x | 78.7x | 82.6x | |||||
| (x) LTM Net Income | 1 | 1 | 1 | |||||
| (=) Equity Value | 56 | 59 | 62 | |||||
| (/) Shares Outstanding | 8.3 | 8.3 | 8.3 | |||||
| Implied Value Range | 6.76 | 7.12 | 7.47 | |||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 6.76 | 7.12 | 7.47 | 10.50 | ||||
| Upside / (Downside) | -35.6% | -32.2% | -28.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 93M1 | B8FK | HIGH | 8RK | EEVIA | APPH | |
| Value of Common Equity | 77 | 16 | 51 | 26 | 1 | 87 | |
| (/) Shares Outstanding | 4.3 | 6.1 | 12.5 | 7.0 | 126.8 | 8.3 | |
| Implied Stock Price | 17.95 | 2.71 | 4.12 | 3.70 | 0.01 | 10.50 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | |
| Implied Stock Price (Trading Cur) | 17.95 | 2.71 | 4.12 | 3.70 | 0.06 | 10.50 | |
| Trading Currency | EUR | EUR | EUR | EUR | SEK | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | |